Shandra Eisenga Human Cell and Tissue Product Safety Act

Floor Speech

BREAK IN TRANSCRIPT

Mr. MOOLENAAR. Mr. Speaker, I thank the gentleman from Florida (Mr. Bilirakis) for yielding and for his strong support for this legislation. I also thank my colleagues on the other side of the aisle, Mr. Pallone, and especially my friend and fellow Michigander, Congresswoman Debbie Dingell, who has worked very closely with me on this legislation.

Mr. Speaker, I rise in support of this bipartisan legislation, H.R. 1082, the Shandra Eisenga Human Cell and Tissue Product Safety Act.

In 2023, 36 patients across 7 States contracted tuberculosis after receiving bone grafts containing infected donor material.

One of these patients was my constituent, Shandra Eisenga, of Marion, Michigan, who tragically passed away on August 10, 2023, due to complications from TB.

I was proud to have Shandra's family here last year when this legislation was first considered by the House. This family has been forever hurt by the loss of Shandra. Her daughter, Amber, said: Nothing can erase the heartbreak of my mother's passing, but she would be proud that we have helped make a positive difference in her name.

Today, we are taking concrete action to prevent more families from having the same experience as Amber and to honor her mother's legacy.

Shandra's passing was completely preventable. So were the deaths of nine other patients who have passed away from TB since 2021 because of inadequate oversight of tissue material suppliers.

When it comes to tissue donations, the FDA requires screening for diseases like hepatitis, syphilis, and HIV. This bipartisan bill will require screening for tuberculosis, as well, and put an end to preventable TB deaths like Shandra's.

The bill will also require HHS to conduct research and public education campaigns on the risks of surgery requiring a tissue donation.

Mr. Speaker, I urge my colleagues to support this vital bipartisan legislation in honor of Shandra and her family.

BREAK IN TRANSCRIPT

Source